AOLS (Aeolus Pharmaceuticals) Common Stock: $1.52 Mil (As of Jun. 2017)


What is Aeolus Pharmaceuticals Common Stock?

Aeolus Pharmaceuticals AOLS Common Stock is $1.52 Mil as of Jun. 2017.

Aeolus Pharmaceuticals's quarterly common stock stayed the same from Dec. 2016 ($1.52 Mil) to Mar. 2017 ($1.52 Mil) and stayed the same from Mar. 2017 ($1.52 Mil) to Jun. 2017 ($1.52 Mil).

Aeolus Pharmaceuticals's annual common stock stayed the same from Sep. 2014 ($1.36 Mil) to Sep. 2015 ($1.36 Mil) but then increased from Sep. 2015 ($1.36 Mil) to Sep. 2016 ($1.52 Mil).

Aeolus Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Aeolus Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aeolus Pharmaceuticals Common Stock Chart

Aeolus Pharmaceuticals Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 1.35 1.36 1.36 1.52

Aeolus Pharmaceuticals Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.52 1.52 1.52 1.52

Aeolus Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $1.52 Mil mean?
Aeolus Pharmaceuticals (AOLS) has a Common Stock of $1.52 Mil as of Jun. 2017. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Aeolus Pharmaceuticals and its competitors.
Is Aeolus Pharmaceuticals' Common Stock too high?
Aeolus Pharmaceuticals' current Common Stock is $1.52 Mil.
How does Aeolus Pharmaceuticals' Common Stock compare to RDGL and PCYN?
Aeolus Pharmaceuticals' Common Stock of $1.52 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Aeolus Pharmaceuticals and its competitors. Aeolus Pharmaceuticals's current Common Stock is $1.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aeolus Pharmaceuticals stock overvalued right now?
Aeolus Pharmaceuticals (AOLS) has a current Common Stock of $1.52 Mil. The current Common Stock is $1.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Aeolus Pharmaceuticals (AOLS), the current Common Stock is $1.52 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aeolus Pharmaceuticals Business Description

Address 26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.